Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Solid Tumors in Oral Presentation at the 2024 ASCO Annual Meeting : vimarsana.com

Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Solid Tumors in Oral Presentation at the 2024 ASCO Annual Meeting

Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Solid Tumors in Oral Presentation at the 2024 ASCO Annual Meeting

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , United States , Chicago , Illinois , Texas , American , Rodaben Amaria , Adamj Schoenfeld , University Of Texas Md Anderson Cancer Center , Vertex Pharmaceuticals , American Society Of Clinical Oncology , Memorial Sloan Kettering Cancer Center , Obsidian Therapeutics Inc , Bristol Myers Squibb , Linkedin , Clinical Oncology , Annual Meeting , Rapid Oral Abstract , Skin Cancers , Lead Author , Trial Identifier , Progress Poster , Poster Session ,